SMTL ID : 6xvj.1

Crystal structure of the KDR (VEGFR2) kinase domain in complex with a type-II inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.78 Å

Oligo State

monomer

Ligands

1 x O35: ~{N}-[3-[(dimethylamino)methyl]-5-methyl-phenyl]-2-[3-methoxy-5-(7-methoxyquinolin-4-yl)oxy-pyridin-2-yl]ethanamide(Non-covalent)

O35.1: 24 residues within 4Å: Chain A: L.35, V.43, A.61, V.62, K.63, E.80, I.83, L.84, I.87, V.94, V.109, V.111, E.112, F.113, C.114, K.115, G.117, I.170, H.171, L.180, I.189, C.190, D.191, F.192 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.35, A:L.35, A:V.43, A:A.61, A:K.63, A:L.84, A:I.87, A:V.111, A:F.113, A:D.191, A:F.192 Hydrogen bonds: A:E.80, A:E.80, A:C.114, A:D.191 Salt bridges: A:D.191

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

McAulay, K. et al., Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors. J.Am.Chem.Soc. (2020)

Release Date

2020-05-27

Peptides

Vascular endothelial growth factor receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Vascular endothelial growth factor receptor 2

Related Entries With Identical Sequence